Orchestra Biomed Holdings Inc Receivables Turnover Ratio (OBIO), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Orchestra Biomed Holdings Inc   (NASDAQ: OBIO)
 

Orchestra Biomed Holdings Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Orchestra Biomed Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 453.56, this represents a new company high. This is a clear indication for improving liquidity at Orchestra Biomed Holdings Inc 's clients. Average collection period, for Orchestra Biomed Holdings Inc 's accounts receivable remained unchanged at 1 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 2 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 41, from overall ranking in the first quarter 2026 at 47.

What is Receivable Turnover Ratio?
What is Orchestra Biomed Holdings Inc Selling?


What is Receivable Turnover Ratio?





OBIO Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change -38.55 % -5.62 % 3.26 % -54.78 % 3.75 %
Y / Y Revenue Change -89.47 % -87.33 % 12120.16 % -12.77 % 7.46 %
Receivable Turnover Ratio (TTM) 453.56 416.87 419.84 35.67 31.07
OBIO's Total Ranking # 41 # 47 # 389 # 447 # 470
Accounts Receivable average collection period days 1 1 1 10 12
Seq. Receivable Change -39.29 % -11.58 % 82.69 % -37.35 % -6.74 %
Seq. Revenue Change -20 % -99.64 % 3490.82 % 2.99 % -3.69 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 2
Healthcare Sector # 3
Overall Market # 41

Receivable Turnover Ratio Statistics
High Average Low
453.56 130.98 20.96
(Jun 30 2026)   (Mar 31 2024)






Financial Statements
Orchestra Biomed Holdings Inc 's Accounts Receivable $ 0 Millions Visit OBIO's Balance sheet
Orchestra Biomed Holdings Inc 's Sales TTM $ 32 Millions Visit OBIO's Income Statement
Sources of OBIO's Revenues Visit OBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OBIO's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OBIO's Growth Rates OBIO's Roa OBIO's Inventory Turnover Ratio OBIO's Dividend Comparisons
OBIO's Profitability Ratios OBIO's Roi OBIO's Asset Turnover Ratio OBIO's Dividend Growth
OBIO's Valuation Ratios OBIO's Roe OBIO's Financial Strength Ratios OBIO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Logicmark Inc  1,686.71 $ 12.544  Millions$ 0.007  Millions
Ainos Inc   508.41 $ 0.014  Millions$ 0.000  Millions
Orchestra Biomed Holdings Inc   453.56 $ 31.976  Millions$ 0.071  Millions
Nakamoto Inc   386.16 $ 28.962  Millions$ 0.075  Millions
Immunocore Holdings Plc  195.08 $ 430.775  Millions$ 2.208  Millions
Agape Atp Corporation  190.27 $ 1.152  Millions$ 0.006  Millions
Hcw Biologics Inc   175.24 $ 6.843  Millions$ 0.039  Millions
Warby Parker Inc   161.02 $ 912.542  Millions$ 5.667  Millions

Date modified: 2026-09-08T21:23:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.